Suppr超能文献

我们能否在 OLS 和受污染的 IV 方法之间做出明智的选择?

Can we make smart choices between OLS and contaminated IV methods?

机构信息

Departments of Health Services, Pharmacy and Economics, University of Washington, Seattle, WA, USA; The National Bureau of Economic Research, Cambridge, MA, USA.

出版信息

Health Econ. 2014 Apr;23(4):462-72. doi: 10.1002/hec.2926. Epub 2013 Jun 13.

Abstract

In the outcomes research and comparative effectiveness research literature, there are strong cautionary tales on the use of instrumental variables (IVs) that may influence the newly initiated to shun this premier tool for casual inference without properly weighing their advantages. It has been recommended that IV methods should be avoided if the instrument is not econometrically perfect. The fact that IVs can produce better results than naïve regression, even in nonideal circumstances, remains underappreciated. In this paper, we propose a diagnostic criterion and related software that can be used by an applied researcher to determine the plausible superiority of IV over an ordinary least squares (OLS) estimator, which does not address the endogeneity of a covariate in question. Given a reasonable lower bound for the bias arising out of an OLS estimator, the researcher can use our proposed diagnostic tool to confirm whether the IV at hand can produce a better estimate (i.e., with lower mean square error) of the true effect parameter than the OLS, without knowing the true level of contamination in the IV.

摘要

在结局研究和比较效果研究文献中,有很多关于工具变量(IV)使用的警示故事,这可能会导致新学者回避这种用于因果推断的主要工具,而不恰当地权衡其优势。有人建议,如果工具变量在计量经济学上并不完美,就应该避免使用 IV 方法。IV 即使在不理想的情况下也能产生比简单回归更好的结果,这一点仍未得到充分认识。在本文中,我们提出了一种诊断标准和相关软件,应用研究人员可以使用这些标准和软件来确定 IV 是否优于普通最小二乘法(OLS)估计量,而后者不能解决所讨论的协变量的内生性问题。给定 OLS 估计量产生偏差的合理下限,研究人员可以使用我们提出的诊断工具来确认手头的 IV 是否可以比 OLS 产生更好的真实效应参数估计(即均方误差更低),而无需了解 IV 的真实污染水平。

相似文献

1
Can we make smart choices between OLS and contaminated IV methods?
Health Econ. 2014 Apr;23(4):462-72. doi: 10.1002/hec.2926. Epub 2013 Jun 13.
3
Bias testing, bias correction, and confounder selection using an instrumental variable model.
Stat Med. 2020 Dec 20;39(29):4386-4404. doi: 10.1002/sim.8730. Epub 2020 Aug 27.
4
Sample size importantly limits the usefulness of instrumental variable methods, depending on instrument strength and level of confounding.
J Clin Epidemiol. 2014 Nov;67(11):1258-64. doi: 10.1016/j.jclinepi.2014.05.019. Epub 2014 Aug 12.
5
Instrumental variables vs. grouping approach for reducing bias due to measurement error.
Int J Biostat. 2008;4(1):Article 8. doi: 10.2202/1557-4679.1087.
6
Dose-response modeling in mental health using stein-like estimators with instrumental variables.
Stat Med. 2017 May 20;36(11):1696-1714. doi: 10.1002/sim.7265. Epub 2017 Feb 21.
7
Evaluating disease management programme effectiveness: an introduction to instrumental variables.
J Eval Clin Pract. 2006 Apr;12(2):148-54. doi: 10.1111/j.1365-2753.2006.00615.x.
8
Use and misuse of the reduced major axis for line-fitting.
Am J Phys Anthropol. 2009 Nov;140(3):476-86. doi: 10.1002/ajpa.21090.

引用本文的文献

1
Effect of Health Literacy on Antiviral Treatment of Hepatitis B: Instrumental Variable Analysis.
JMIR Public Health Surveill. 2024 Dec 16;10:e58391. doi: 10.2196/58391.
4
Instrumental variable methods for causal inference.
Stat Med. 2014 Jun 15;33(13):2297-340. doi: 10.1002/sim.6128. Epub 2014 Mar 6.

本文引用的文献

2
Efficacy of phototherapy for newborns with hyperbilirubinemia: a cautionary example of an instrumental variable analysis.
Med Decis Making. 2012 Jan-Feb;32(1):83-92. doi: 10.1177/0272989X11416512. Epub 2011 Aug 21.
4
When and how to use instrumental variables in palliative care research.
J Palliat Med. 2009 May;12(5):471-4. doi: 10.1089/jpm.2009.9631.
5
Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling.
J Health Econ. 2008 May;27(3):531-43. doi: 10.1016/j.jhealeco.2007.09.009. Epub 2007 Dec 4.
6
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
N Engl J Med. 2005 Sep 22;353(12):1209-23. doi: 10.1056/NEJMoa051688. Epub 2005 Sep 19.
7
Economic outcomes associated with olanzapine versus risperidone in the treatment of uncontrolled schizophrenia.
Curr Med Res Opin. 2004 Jul;20(7):1039-48. doi: 10.1185/030079904125004097.
9
Olanzapine versus risperidone. A prospective comparison of clinical and economic outcomes in schizophrenia.
Pharmacoeconomics. 2000 Dec;18(6):567-79. doi: 10.2165/00019053-200018060-00004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验